FOS and breast carcinoma: As evidenced by the IC50 values (Table 2), FOS stands out for its marked cytotoxicity in all the cell lines, with a greater potency in MDA-MB-468 breast cancer cells (IC50 approximately 1.4 and 2.0 times lower than those in Caco2 and H358).